Scopus BioPharma Inc. Gains 90.91%

Wed, May 22, 2024 at 07:20 PM

Scopus BioPharma Inc. (SCPS:NASDAQ) rocketted at $0, a gain of 90.9%. From Wed, May 08, 2024, the stock recorded 0.00% Up Days and 0.00% Green Days

About Scopus BioPharma Inc. (SCPS:NASDAQ)

Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system.

Top 10 Gainers:

Akoustis Technologies, Inc. (AKTS:NASDAQ), 128.83%
Schmitt Industries, Inc. (SMIT:NASDAQ), 117.65%
Barnes & Noble Education, Inc. (BNED:NYSE), 109.22%
Scopus BioPharma Inc. (SCPS:NASDAQ), 90.91%
F45 Training Holdings Inc. (FXLV:NYSE), 66.67%
Binah Capital Group Inc. (BCG:NASDAQ), 56.88%
Kubient Inc. (KBNT:NASDAQ), 50%
IGM Biosciences, Inc. (IGMS:NASDAQ), 36.39%
Vinco Ventures Inc. (BBIG:NASDAQ), 34.38%
Greenwave Technology Solutions Inc. (GWAV:NASDAQ), 33.79%